Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of recombinant human growth hormone on circulating Klotho levels in healthy volunteers and CKD patients
2013-003354-24Phase 3Active
- Sponsor
- Amsterdam University Medical Center
- Start
- Oct 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of somatropin in chronic kidney disease (CKD) and cardiac morbidity (2 cohorts), sponsored by Amsterdam University Medical Center. Primary endpoints: Change in soluble Klotho levels after rhGH administration (primary) and Change in soluble Klotho levels after single rhGH dose (primary as restated). Started Oct 2014; status: active.
02
Drugs
somatropin
03
Conditions
chronic kidney disease (CKD)cardiac morbidity
Beyond the preview
Go deeper on 2013-003354-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003354-24.